Onc Now features expert Kevin Harrington dissecting the evolving landscape of head and neck cancer treatment. The discussion highlights the transformative impact of immunotherapy and the emerging promise of oncolytic viruses. Harrington reflects on past challenges, the integration of radiotherapy and systemic therapies, and the crucial step of translating scientific innovation into tangible clinical benefits.
The conversation delves into specific areas like salivary gland cancers and strategic combination therapies. Harrington, Professor of biological cancer therapies at the Institute of Cancer Research and consultant clinical oncologist at the Royal Marsden NHS Foundation Trust, shares insights crucial for the next generation of oncologists navigating this rapidly advancing field.